[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100500915":3},{"organization":4,"outcomesModule":7,"designInfo":57,"detailedDescription":60,"studyPopulation":61,"armGroups":62,"interventions":72,"overallOfficials":94,"centralContacts":99,"locations":108,"responsibleParty":127,"collaborators":56,"id":131,"slug":56,"hasResults":132,"nctId":133,"briefTitle":134,"officialTitle":135,"acronym":136,"eligibilityCriteria":137,"healthyVolunteers":132,"sex":138,"minAge":139,"maxAge":56,"enrollmentInfo":140,"targetDuration":143,"studyType":144,"phases":56,"briefSummary":145,"conditions":146,"keywords":149,"overallStatus":111,"whyStopped":56,"lastUpdateSubmitDate":154,"lastUpdatePostDateStruct":155,"startDateStruct":158,"completionDateStruct":160,"leadSponsor":162,"locationsCount":163},{"fullName":5,"class":6},"Hospital Universitari de Bellvitge","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":16,"otherOutcomes":56},[9,13],{"measure":10,"description":11,"timeFrame":12},"Quality of life related to the swallowing function assessed using the EORTC QLQ OG25, EORTC QLQ C30, GIQLI and SWAL QoL questionnaire.","This study aims to determine the differences in the quality of life of patients undergoing complex esophageal reconstruction by jejunoplasty (free, pedunculated ± supercharged) or coloplasty (± supercharged) using the following questionnaires:\n\n* European Organisation for Research and Treatment of Cancer Quality-of-life Questionnaire Core 30 (EORTC QLQ C30): All of the scales and single-item measures range in score from 0 to 100. A high scale score represents a higher response level.\n* European Organisation for Research and Treatment of Cancer Quality-of-life Questionnaire Oesophago Gastric module 25 (EORTC QLQ OG25): All of the scales and single-item measures range in score from 0 to 100. A high score for all the scales and single-items represents a high level of symptomatology or problems.\n* Gastrointestinal quality of life index (GIQLI): scale range from 0-144\n* Swallowing quality of life questionnaire (SWAL QoL): scale range from 0-100","The follow-up of each patient included in the study will end 3 years after the intervention when the End of Study visit will be carried out.",{"measure":14,"description":15,"timeFrame":12},"Number (percentage) of patients who present tolerance to the oral intake and need (volume in milliliters) of enteral nutrition depending on the type of conduit.","This study aims to describe the functional evolution of complex esophageal reconstruction by jejunoplasty (free, pedunculated ± supercharged) or coloplasty (± supercharged).",[17,20,23,26,29,32,35,38,41,44,47,50,53],{"measure":18,"description":19,"timeFrame":12},"Incidence of dysphagia","Incidence of dysphagia evaluated by Videofluoroscopic (VDF) using the following scales:\n\n* Videofluoroscopic dysphagia scale (VDS)\n* Dysphagia outcome and severity scale(DOSS)\n* Penetration-aspiration scale(PAS)",{"measure":21,"description":22,"timeFrame":12},"Incidence of stenosis of the conduit","Incidence of stenosis of the conduit in the Upper Digestive Endoscopy (UDE) that requires some therapeutic maneuver (dilatation), which is carried out during the follow-up visits: one year, two and three years.",{"measure":24,"description":25,"timeFrame":12},"Number (percentage) of dilatations of the conduit","Number (percentage) of dilatations of the conduit, per patient, carried out during the UDE within the follow-up visits: one year, two and three years.",{"measure":27,"description":28,"timeFrame":12},"Number (percentage) of patients with esophagitis","Number (percentage) of patients with esophagitis according to the Los Angeles classification evidenced in any of the UDE performed during the follow-up visits: one year, two and three years.",{"measure":30,"description":31,"timeFrame":12},"Number (percentage) of patients with chronic diarrhea","Number (percentage) of patients with chronic diarrhea during follow-up",{"measure":33,"description":34,"timeFrame":12},"Body Mass Index","Weight and height will be combined to report Body Mass Index (BMI kg\u002Fm2) as a measure for indicating nutritional status",{"measure":36,"description":37,"timeFrame":12},"Muscle strength measured by Handgrip strength (HGS) dynamometer","Handgrip strength expressed in Kg and assessed using the reference values for age and sex",{"measure":39,"description":40,"timeFrame":12},"Serum albumin value","Measure of albumin\u002Fprealbumin in blood tests for assessment of nutritional status. Normal value: 34 - 54 g\u002FL",{"measure":42,"description":43,"timeFrame":12},"Mean 'time of need for enteral nutrition and oral nutrition supplements'","Mean 'time of need for enteral nutrition and oral nutrition supplements' during the post-surgical follow-up period.",{"measure":45,"description":46,"timeFrame":12},"Volume of enteral nutrition required","Volume of enteral nutrition required during the post-surgical follow-up period.",{"measure":48,"description":49,"timeFrame":12},"Number of hospitalizations","Number of hospitalizations, for any reason, during the post-surgical follow-up period.",{"measure":51,"description":52,"timeFrame":12},"Number (percentage) of specific complications of the surgery during admission according to the Esophageal Complication Consensus Group (ECCG)","Number (percentage) of specific complications of the surgery during admission according to the Esophageal Complication Consensus Group (ECCG) (20), highlighting anastomotic dehiscence, surgical site infection, bleeding, need for reintervention, ischaemia of the graft (up to 90 ±3 days after surgery). Number (percentage) of complications according to the Clavien-Dindo classification (21) and Comprehensive Complication Index.",{"measure":54,"description":55,"timeFrame":12},"Mortality","Number (percentage) of deaths related to esophageal reconstruction (Up to 90 ±3 days after surgery).",null,{"allocation":56,"interventionModel":56,"interventionModelDescription":56,"primaryPurpose":56,"observationalModel":58,"timePerspective":59,"maskingInfo":56},"COHORT","PROSPECTIVE","-General Justification: In recent years, esophageal reconstruction has been a great surgical challenge for the multidisciplinary teams in charge of carrying out this complex technique, associated with high morbidity and a high impact on the quality of life and functional status of patients.\n\nOne of the most important aspects of this surgery is the type of conduit used to restore digestive transit. Classically, gastroplasty has been the technique of choice due to its lower morbidity and mortality and less surgical complexity. On the other hand, in those patients in whom the stomach is not available, a coloplasty or a jejunoplasty is chosen, both of which can be associated with supercharged techniques to improve and ensure good vascular flow.\n\nCurrently, there is controversy about which type of conduit to use in the absence of a viable stomach. Since the introduction of microvascular or supercharged techniques, the postoperative results of jejunal grafts are comparable to coloplasty and even gastroplasty according to some authors.\n\nThe present study is an initiative of the Complex Esophageal Reconstruction Unit (UREC) of Bellvitge University Hospital (HUB), which aims to compare the different types of conduit used in complex esophageal reconstruction, assessing, in the short and long term, the postoperative functional status and its impact on quality of life through validated test-type tools, as well as carrying out complementary tests that allow evaluating aspects such as swallowing and dysphagia, among others.\n\n* Hypothesis Considering the results of quality of life and functionality in the short and long term, jejunoplasty (free, pedunculated ± supercharged) could be the second technique of choice to perform in the absence of gastric conduit in complex esophageal reconstruction.\n* Primary objective:\n\n  1. To determine the differences in the quality of life of patients undergoing complex esophageal reconstruction by jejunoplasty (free, pedunculated ± supercharged) or coloplasty (± supercharged).\n  2. To describe the functional evolution of complex esophageal reconstruction by jejunoplasty (free, pedunculated ± supercharged) or coloplasty (± supercharged).\n* Study design CEREC-2022 is a prospective population-based cohort study that aims to assess the evolution of the functional status of patients undergoing complex esophageal reconstruction and its impact on quality of life, depending on the type of conduit performed.\n* Study population The target population of this study is made up of patients who are candidates for complex esophageal reconstruction performed by the Complex Esophageal Reconstruction Functional Unit of the Bellvitge University Hospital (UREC-HUB), during the study period. All patients who are candidates for complete replacement of the esophagus through reconstruction are presented to the Committee of the Complex Esophageal Reconstruction Functional Unit of the Bellvitge University Hospital (UREC-HUB). After the multidisciplinary assessment, the most appropriate type of surgery for each patient is proposed and the patient receives the information during a scheduled appointment, at this moment the patient is asked to participate in the CEREC-2022 study.\n* Main Outcome\n\n  1. Quality of life related to the swallowing function based on the conduit: it will be assessed using the European Organisation for Research and Treatment of Cancer Quality-of-life Questionnaire Core 30 (EORTC QLQ C30), European Organisation for Research and Treatment of Cancer Quality-of-life Questionnaire Oesophago Gastric module 25 (EORTC QLQ OG25), Gastrointestinal quality of life index (GIQLI) and Swallowing quality of life questionnaire (SWAL QoL)\n  2. Number (percentage) of patients who present tolerance to the oral intake and need (volume in milliliters) of enteral nutrition depending on the type of conduit.\n* Secondary outcome Incidence of dysphagia evaluated by Videofluoroscopy (VDF), Incidence of stenosis of the conduit in the Upper Digestive Endoscopy (UDE), Number (percentage) of dilatations of the conduit, Number (percentage) of patients with esophagitis according to the Los Angeles classification, Nutritional status, Number (percentage) of specific complications of the surgery during admission according to the Esophageal Complication Consensus Group, Number of hospitalizations.\n* As this is an observational study of a low-prevalent surgical indication, it is expected to include all patients scheduled for surgery from September 2022 to September 2025.\n* The follow-up of each patient included in the study will end 3 years after the intervention when the End of Study visit will be carried out.","The target population of this study is made up of patients who are candidates for complex esophageal reconstruction performed by the Complex Esophageal Reconstruction Functional Unit of the Bellvitge University Hospital (UREC-HUB), during the study period.\n\nAll patients who are candidates for complete replacement of the esophagus through reconstruction are presented to the Committee of the Complex Esophageal Reconstruction Functional Unit of the Bellvitge University Hospital (UREC-HUB). After the multidisciplinary assessment, the most appropriate type of surgery for each patient is proposed and the patient receives the information during a scheduled appointment, at this moment the patient is asked to participate in the CEREC-2022 study.",[63],{"label":64,"type":56,"description":65,"interventionNames":66},"Patients undergoing complex esophageal reconstruction","All the patients who are candidates for complex esophageal reconstruction performed by the Complex Esophageal Reconstruction Functional Unit of the Bellvitge University Hospital (UREC-HUB), during the study period.",[67,68,69,70,71],"Other: EORTC QLQ-C30","Other: EORTC QLQ-OG25","Other: GIQLI","Other: SWAL QoL","Procedure: Videofluoroscopy",[73,77,81,85,89],{"type":6,"name":74,"description":75,"armGroupLabels":76,"otherNames":56},"EORTC QLQ-C30","central generic questionnaire associated with different disease specific modules",[64],{"type":6,"name":78,"description":79,"armGroupLabels":80,"otherNames":56},"EORTC QLQ-OG25","module to assess the quality of life in patients with esophagogastric disease.",[64],{"type":6,"name":82,"description":83,"armGroupLabels":84,"otherNames":56},"GIQLI","Gastrointestinal Quality of Life Index. It is a gastrointestinal quality of life scale.",[64],{"type":6,"name":86,"description":87,"armGroupLabels":88,"otherNames":56},"SWAL QoL","Swallowing Quality of Life questionnaire. This is a quality of life and quality of attention questionnaire for patients with oropharyngeal dysphagia.",[64],{"type":90,"name":91,"description":92,"armGroupLabels":93,"otherNames":56},"PROCEDURE","Videofluoroscopy","It consists of 14 items that represent the oral and pharyngeal function observed in the VDF. It allows to quantify the severity of dysphagia.",[64],[95],{"name":96,"affiliation":97,"role":98},"Leandre Farran","Bellvitge University Hospital","STUDY_DIRECTOR",[100,105],{"name":101,"role":102,"phone":103,"phoneExt":56,"email":104},"Monica Miró","CONTACT","+34932607500","mmiro@bellvitgehospital.cat",{"name":106,"role":102,"phone":103,"phoneExt":56,"email":107},"Rodrigo Hermoza","rhermoza@bellvitgehospital.cat",[109],{"facility":110,"status":111,"city":112,"state":56,"zip":113,"country":114,"countryCode":115,"cosmosGeoPoint":116,"geoPoint":121,"contacts":122},"Hospital Uversitari de Bellvitge","RECRUITING","Barcelona","08907","Spain","ES",{"type":117,"coordinates":118},"Point",[119,120],2.15899,41.38879,{"lat":120,"lon":119},[123,126],{"name":124,"role":102,"phone":125,"phoneExt":56,"email":104},"Mònica Miró","+34 932 60 75 00",{"name":106,"role":102,"phone":125,"phoneExt":56,"email":107},{"type":128,"investigatorFullName":129,"investigatorTitle":130,"investigatorAffiliation":5,"oldNameTitle":56,"oldOrganization":56},"PRINCIPAL_INVESTIGATOR","Mònica Miró Martín","Associate surgeon and specialist in Upper Gastrointestinal surgery. PhD, MD.","100500915",false,"NCT05802459","Evaluation of the Functional Status of Jejunoplasty and Coloplasty and Its Impact on Quality of Life (CEREC)","Prospective Evaluation of the Functional Status of Jejunoplasty and Coloplasty in Patients Undergoing Complex Esophageal Reconstruction and Its Impact on Quality of Life (CEREC)","CEREC","Inclusion Criteria:\n\n* Adult patients (≥ 18 years of age) and of both gender.\n* Candidates for complete esophageal reconstruction with cervical anastomosis, regardless of the etiology of the esophagectomy.\n* Decision to indicate a coloplasty (+\u002F- supercharged) or jejunoplasty (free, pedunculated +\u002F- supercharged) as surgical technique after evaluation by the UREC Committee.\n* Acceptance to participate in the study and comply with the program of procedures (schedule of visits).\n* Signing of the informed consent.\n\nExclusion Criteria:\n\n* Patients who withdraw their informed consent at any time during the course of the study.","ALL","18 Years",{"count":141,"type":142},36,"ESTIMATED","3 Years","OBSERVATIONAL","The goal of this prospective population-based cohort study is to assess:\n\n* The evolution of the functional status of patients undergoing complex esophageal reconstruction\n* Its impact on quality of life, depending on the type of conduit performed.\n\nParticipants\n\n* Will be asked to complete different quality of life questionnaires during every follow-up visit\n* Will undergo additional tests to assess functionality",[147,148],"Quality of Life","Dysphagia",[150,151,152,153,148],"Esophageal reconstruction","Quality of life","Coloplasty","Jejunoplasty","2023-03-27",{"date":156,"type":157},"2023-04-06","ACTUAL",{"date":159,"type":157},"2022-12-15",{"date":161,"type":142},"2027-09",{"name":5,"class":6},1]